Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to INR 283 crore in the third quarter ended December 31, 2022. The drug firm had reported a net profit of INR 249 crore in the October-December period of previous fiscal.
Net sales increased to INR 2,459 crore in the quarter under review as against INR 2,092 crore in the year-ago period, the company said in a regulatory filing. The company’s board, which met on Wednesday, declared an interim dividend of INR 14 (280 per cent) per share of INR 5 each. On Wednesday, shares of the company ended 1.86 per cent down at INR 1,557.50 apiece on the BSE